Sunstone Capital — Full Portfolio
55 tracked investments · listed companies and verified rows first
Amgen is an independent biotechnology company that uses science and technology, including machine learning and human genetic data, to research and develop treatments for serious diseases such as cancer, heart disease, asthma, and osteoporosis.
AI & Machine LearningBiotechThousand Oaks, US
David Piacquad(Executive Officer)Brian M. McNamee(Executive Officer)inRobert A. Bradway(Executive Officer, Director)David J. Scott(Executive Officer)Madhavan Balachandran(Executive Officer)Stuart A. Tross(Executive Officer)in
Co-investorsAsset Management CompanyMayfield Fund
DiogenX is a preclinical-stage biotech company developing biologic therapeutics aimed at restoring insulin-producing beta cells for people with Type 1 diabetes.
BiotechDeep TechDigital HealthHealthtechMarseille, FR
Benjamin Charles(Co-Founder & CEO)inPatrick Collombat(Co-Founder & Scientific Advisor)inJean-Pascal Tranié(Co-Founder)in
Co-investorsAdBio partnersRoche Venture FundBoehringer Ingelheim Venture FundJDRF T1D Fund
MinervaX is a biotech company developing prophylactic vaccines, with therapeutic focus areas including immunology and infectious disease.
BiotechHealthtech
PerBengt(CSO)
Co-investorsAdjuvant CapitalIndustrifondenOrbiMedPureos BioventuresSanofi VenturesEQT Life Sciences+2 more
Acarix provides diagnostic systems and supports investigator-initiated clinical trials and research projects to advance medical knowledge in cardiovascular disease assessment.
Digital HealthHealthtechMedical Devices
Co-investorsSEED Capital Denmark
Tula Tula Blankets manufactures hand-brushed and woven blankets using ethically sourced materials, produced in South Africa with a focus on fair labor practices and community empowerment in Southern Africa.
Circular EconomyConsumerDirect to ConsumerImpact & Social GoodSouth Africa, ZA
Co-investorsCraigie CapitalCrane Venture PartnersExperian VenturesOrange Digital VenturesSparkLabs Global VenturesWhite Star Capital
Alligator Bioscience AB is a biotechnology company whose shares are listed on NASDAQ Stockholm (Small Cap) under the ticker ATORX.
BiotechHealthtechLund, SE
Carl Borrebaeck(Director)in
BoardPeter Benson(Director)Mathias Uhlen(Director)Claes Ericsson(Director)Jacob Lindberg(Director)Kenth Petersson(Director)
Arcoma develops high-end radiology and X-ray imaging systems, integrating detectors and imaging software through partnerships with technology providers such as Canon Medical Systems and Varex.
Advanced ManufacturingHardwareHealthtechMedical DevicesVäxjö, SE
Mattias Leire(VD (CEO))inMattias Guldstrand(CTO)inGöran Edwall(Interim CFO)André Malmberg(COO)in
Co-investorsEiffel Investment Group
Ascelia Pharma is a biotech company developing and commercializing drugs for rare, orphan oncology-related conditions with unmet medical needs.
BiotechHealthtechMedical DevicesMalmö, SE
Magnus Corfitzen(Chief Executive Officer)inAndreas Norlin(Chief Scientific Officer)inJennie Wilborgsson(Chief Operating Officer)inAnton Hansson(Chief Financial Officer)in
Co-investorsLumira Ventures
Audibene sells hearing aids and related digital solutions for people with hearing loss through Germany's largest network of partnered acousticians.
Digital HealthHealthtechMedical DevicesBerlin, DE
Co-investorsActon CapitalHeartcore CapitalSTS Ventures GmbH
Blackwood Seven builds HamiltonAI, a Bayesian AI platform that links marketing and media investments to sales results to help marketers measure media effectiveness and optimize ROI.
AdTechAI & Machine LearningMarketing Tech
Co-investorsJolt CapitalSeed Capital Limited
Boozt is an online retailer offering fashion and lifestyle products to consumers, with a mobile app and delivery service.
ConsumerE-commerceRetail Tech
Peter G. Jørgensen(Founder)in
Co-investorsFriheden InvestHeartcore Capital
Co-investorsBioMedPartnersInkef
New York, US
Suchit Dash(Executive Officer)Jonas Druppel(Founder)in
BoardDanny Rimer(Director)
Co-investorsBalderton CapitalEniac VenturesIndex VenturesLowercase CapitalRaine
Egalet develops medicines for people living with moderate to severe pain, including approved and licensed pain products.
BiotechHealthtechMedical DevicesWayne, US
BARBARA A. CARLIN(SENIOR VICE PRESIDENT AND CHIEF ACCOUNTING OFFICER)ROBERT S. RADIE(CHIEF EXECUTIVE OFFICER)MARK STROBECK(EXECUTIVE VICE PRESIDENT AND CHIEF OPERATING OFFICER)MEGAN TIMMINS(SENIOR VICE PRESIDENT AND GENERAL COUNSEL)PATRICK M. SHEA(SENIOR VICE PRESIDENT AND CHIEF COMMERCIAL OFFICER)Jeffrey M. Dayno(Chief Medical Officer)
Co-investorsAtlas Venture
Evolva (EvoNext Holdings SA / Evolva Holding AG) develops and markets flavour and fragrance products.
BiotechFoodTechNew Materials
Co-investorsVenturEastEntrepreneurs FundNice & Green
F2G develops medicines to treat serious fungal diseases where existing therapies have failed or are ineffective.
BiotechDigital HealthHealthtechMedical Devices
Co-investorsAdvent Life SciencesAisling CapitalAMR Action FundAstellas Venture Management LLCBrace PharmaSofinnova Partners+3 more
Co-investorsInnovestor VenturesM Ventures
Damora Therapeutics is a biotechnology company developing subcutaneous biologics as targeted, disease-modifying treatments for patients with mutant calreticulin (mutCALR)-driven myeloproliferative neoplasms such as essential thrombocythemia and myelofibrosis.
BiotechMedical Devices
Jennifer Jarrett(Chief Executive Officer & Board Director)inSherwin Sattarzadeh(Chief Operating Officer)inBecker Hewes(Chief Medical Officer)Garrett Winslow(General Counsel)inJim Baker(Chief Corporate Affairs Officer)inBrian Burkavage(Senior Vice President, Finance)in
Co-investorsEIR VenturesHadean VenturesM VenturesSEED Capital DenmarkYsios CapitalMaverick Ventures+1 more
Grandhood provides pension advisory and financial services in Denmark.
FintechDenmark, DK
Erik Frandsen(Kaptajn & Ejer)Morten Dyhrberg Wewer(Co-CEO)inAdam Ørskov(Co-CEO)in
Co-investorsSEED Capital DenmarkSeed Capital Limited
IOBiotech appears to be a biotech company focused on oncology, with a founder who has extensive experience in cancer drug development and clinical advancement from roles at Roche, Eli Lilly, and leading academic cancer centers.
BiotechMedical Devices
Dr. Dhingra
Co-investorsAvoro Capital AdvisorsEIR VenturesKurma PartnersRA CapitalSamsara BioCapitalVivo Capital+2 more
Jurag Separation A/S was a Danish industrial biotech company that developed REED (Reverse Electro-Enhanced Dialysis) membrane separation technology to boost yields in fermentation and bioprocessing for pharma, biotech, food, and feed industries.
Kynexis is a clinical-stage biotech developing KYN-5356, an oral small-molecule KAT-II inhibitor targeting the kynurenine pathway to improve cognition in neurological diseases.
BiotechDeep TechHealthtech
Robert Schwarcz(Scientific Co-founder)Carol Tamminga(Scientific Co-founder & Chair of the SAB)Christer Köhler(Founding Director)inKees Been(Chief Executive Officer)inJens Wendland(Chief Medical Officer)inNeil Swami(Chief Business Officer)
Co-investorsYsios CapitalForbionNovartis Venture Fund
Mojiworks develops games that connect communities through social play on platforms like Discord, Reddit, and Snapchat.
AI & Machine LearningCreator EconomyGaming
Matthew Wiggins(CEO)in
Co-investorsBalderton CapitalLifeline VenturesHeartcore Capital
Neumirna develops miRNA-based therapies for neurological diseases such as epilepsy and Parkinson's.
BiotechLongevity
Co-investorsIaso VenturesInvivo Capital Partners
Nuevolution was a Copenhagen-based biopharmaceutical company developing small-molecule drugs for oncology and chronic inflammatory diseases using its proprietary DNA-encoded chemical library platform, Chemetics.
Co-investorsIndustrifonden
Obliquet develops therapeutics using an antibody platform called AbiProt to create novel medicines targeting disease-modifying human proteins, focusing on severe diseases with unmet clinical needs such as pain management.
AI & Machine LearningBiotechDigital HealthMedical DevicesStockholm, SE
OxThera develops a live biotherapeutic product based on oxalate-degrading bacteria to treat primary hyperoxaluria and other rare kidney diseases.
BiotechHealthtechMedical DevicesStockholm, SE
Elisabeth Lindner(Chief Operating Officer)Mats-Olof Wallin(Chief Financial Officer)Milt Allison
Co-investorsYsios Capital
Peakon (Workday Peakon Employee Voice) is an AI-powered employee listening platform that collects and analyzes staff feedback to help organizations measure engagement, forecast turnover, and support leadership development and DEI efforts.
AI & Machine LearningHR TechSaaS
Co-investorsBalderton CapitalEmblemMoonfire VenturesAtomicoEQT VenturesIdinvest Partners
PreciSense A/S was a Danish medical technology company developing semi-invasive continuous glucose monitoring sensors for diabetes management.
Prexton Therapeutics was a biopharmaceutical company developing novel therapies for Parkinson's disease, including its lead mGluR4 modulator candidate foliglurax.
BiotechHealthtechMedical DevicesCopenhagen, DK
Co-investorsCardinal PartnersM VenturesSeroba Life SciencesYsios Capital
Resalis Therapeutics develops antisense oligonucleotide therapies targeting microRNA pathways for metabolic disorders.
BiotechHealthtechLongevityMedical DevicesTurin, IT
Riccardo Panella(Chief Scientific Officer & Co-Founder)inSakari Kauppinen(Chief Technology Officer & Co-Founder)in
Co-investorsClaris VenturesItalian Angels for Growth
Biopharmaceutical company targeting RIG-I for immune-mediated treatment of cancer and viral diseases; acquired by Merck in 2017.
Co-investorsMC Healthcare Ventures
Rewind Therapeutics is a biotech company focused on neurodegeneration and neuroimmune diseases, with leadership and scientific advisory expertise in drug discovery, clinical development, and translational research for conditions like multiple sclerosis and Alzheimer's disease.
BiotechDeep TechDigital HealthHealthtechMedical DevicesLeuven, BE
Jim Van Heusden(Executive Chair)Irene Knuesel(Chief Scientific Officer)Christophe Van Vaeck(Chief Financial Officer)Ricardo Hermosilla(Head of Translational Medicine)Stephen Burbidge(VP Preclinical Drug Development)
Co-investorsBoehringer Ingelheim Venture FundPMVM Ventures
Step Pharma develops oral cancer drugs that inhibit the enzyme cytidine triphosphate synthase 1 (CTPS1), with its lead therapeutic dencatistat in clinical development for lymphoma, solid tumors, and essential thrombocythaemia.
BiotechDeep TechMedical DevicesSaint-Genis-Pouilly, FR
Alain Fischer(Founding Scientist)
Co-investorsHadean VenturesKurma PartnersBpifrancePontifax Venture CapitalV-Bio Ventures
Synendos is a biotech company developing selective endocannabinoid reuptake inhibitors targeting the endocannabinoid system to treat neuropsychiatric disorders.
BiotechDeep TechDigital HealthMental HealthBasel, CH
Prof. Jürg Gertsch(Founder)Dr. Andrea Chicca(Co-Founder & Chief Executive Officer)Dr. Simon Russell(Co-Founder & Chief Commercial Officer)
Co-investorsKurma PartnersYsios Capital
TargED is a biopharmaceutical company developing therapeutics for thrombotic disorders, spun out from University Medical Center Utrecht.
BiotechMedical DevicesUtrecht, NL
Coen Maas(Co-founder)inSteven de Maat(Chief Scientific Officer)inMarc van Moorsel(Director of Operations)inKristof Vercruysse(Chief Executive Officer)inRob Dekker(Vice President CMC)inFilip Van den Wyngaert(Vice President Asset Management)in
Co-investorsAndera PartnersCurie CapitalFund+Hadean VenturesRotripBioGeneration Ventures+1 more
Teitur Trophics is a biotech company developing therapies that target the sortilin family of receptors (SorCS-receptor biology) to activate the brain's natural survival pathways and preserve brain function.
BiotechDeep TechHealthtechLongevityAarhus, DK
Simon Mølgaard(Co-founder & CEO)inAnders Dalby(Co-founder)inMathias Ollendorff(Co-founder)inSimon Glerup(Co-founder)in
Co-investorsIndustrifondenP53 InvestInnovestorSound Bioventures
Tink operates a cloud-based open banking platform accessed through a single API, offering payment initiation and account data aggregation/enrichment services under its own PSD2 license.
Data & InfrastructureFintechSaaS
Daniel Kjellén(Founder)in
Co-investorsDawn CapitalFinTech VenturesInsight PartnersOpera Tech VenturesEurazeo
Traplight is a game development studio that creates games with user-generated content (UGC) features, working on its own original IPs as well as titles built with high-profile brand partners.
Gaming
Co-investorsEQT VenturesHeartcore CapitalKorea Investment PartnersPlay Ventures
VAXIMM is a clinical-stage biopharmaceutical company developing oral T-cell immunotherapies for cancer, based on technology invented at UC San Diego.
BiotechDigital HealthHealthtech
Andreas Niethammer(Founder & Chief Executive Officer)in
Co-investorsAvoro Capital AdvisorsKurma PartnersOberland Capital
Zolar operates an online platform that connects homeowners in Germany with vetted regional installation companies for solar and clean-energy projects, including photovoltaic systems, balcony power plants, wallboxes, and solar storage.
CleantechEnergyMarketplaces
Alex Melzer(Founder)in
Co-investorsEnergy Impact PartnersInven CapitalBNP ParibasStatkraft Ventures
Zymenex was a Danish biopharmaceutical company developing enzyme replacement therapies, such as Lamazym, for rare lysosomal storage diseases like alpha-mannosidosis.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.